Full review of Tilray and stock analysis. 300% upside and 25-50% downside potential
Company milestones in past years were very significant , they managed to keep growth during the pandemic.
However Tilray was one of many stocks which Witnessed stock rally at beginning of 2021 with many retail investors joining the market .
and opened the door for big players to take advantage of this situation and short the stock. Current share shorted is 43 million which is a lot and that is one of the reasons that pushing stock down. The fact that it increased in last months is not a positive sign .
However i didn’t find any sign that shows the company is in danger, which means company is on track to grow and there is no threat to the company.
 that is important point because those who currently shorted this stock are not expecting the company to go out of business .
but they are just aiming a lower stock price and possibly new year to cover their positions.
 to avoid pay taxes for this in 2022 since they are in a good profit, Overall i think we will see reduction of short interest in many stocks during Q1 or Q2 , 2022.
As you know a company is not stock and stock is not a company.
In my point of view we are going to see decline in near term, as we are in December and many investors will reduce exposure to stock that are in red for Tax reasons, Many investors will join again.
Most importantly company now is focused to reduce costs and increase revenue , the company believe they can manage over 1 billion dollar revenue before end of 2024 , and after that i believe with cannabis legalization in Germany , company will be able to operate strongly in Germany since they are currently building the Foundation.
The company managed to build strategic bases in different countries and markets in past years . I believe this company will keep growth in coming years and will become one of the leading company world wide in this field.
If we try to put the puzzle pieces together we will realize that the company revenue increased significantly in last 4 years and also due to their acquisitions their debt is also increased to almost $1 billion .
Current revenue is $0.5 billion , so with 24% gross margin and coming catalysts like legalization in Germany, we can expect stock price to rise over 300% from current level in next 2 or 3 years . However from the negative point view , we can see 25% to 50% downside potential in short term.  Personally i like the company and fundamentals and i will keep them in top of my Watchlist.
Please be aware this information are my personal thoughts and please keep in mind you need to always research yourself too ,maybe you see and noticed something that i missed, If you did find something please share them with me in the comments.

source